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Abstract
Background: Schizophrenia is a chronic, debilitating mental disorder characterized by positive
(e.g., hallucinations, delusions) and negative (e.g., catatonia, flat affect) signs and symptoms.
Many studies suggest that individuals born in winter or spring months are at increased risk for
schizophrenia.
Study Objectives: 1) To determine whether season of birth affects risk for schizophrenia in the
Irish Study of High Density Schizophrenia Families (ISHDSF). 2) To examine, by computer
simulation, power to detect genetic associations with schizophrenia under a variety of conditions
and using different analytic strategies. 3) To test whether specific genes are associated with
schizophrenia in the Irish Case Control Schizophrenia Study (ICCSS), using different analytic
strategies to account for season of birth.
Methods: A case-control design was used to examine the relationship between schizophrenia and
season of birth. Cases were individuals from the ISHDSF diagnosed with schizophrenia.
Controls were the general population of Ireland, with data provided by Ireland’s Central
Statistics Office (CSO). The birth frequencies for each month or quarter were compared in the
two groups by a chi square test. Computer simulations were conducted to examine power to
detect schizophrenia susceptibility loci using either all cases or only cases born in high-risk
months, under different conditions and models for how genetic risk and season of birth interact
to influence risk for schizophrenia. Data for six genetic markers from the ICCSS were analyzed
for evidence of association, using all cases, and then using only cases born in high-risk months.
Setting and Study Participants: ISHDSF families were ascertained through inpatient psychiatric
care facilities serving >95% of the Irish population. Diagnoses were established using DSM-IIIR criteria, and birthdates were recorded for all individuals. The Irish CSO provided aggregate,
population-level data for number of births in Ireland by month for the years 1976-2000 and by
quarter for the years 1900-2000. The ICCSS is a sample of schizophrenic and control individuals
who have been genotyped at many loci across the genome. Schizophrenics were ascertained
through in- and outpatient psychiatric facilities, had diagnoses verified by an expert, and their
birthdates recorded. Controls were selected from several sources, e.g. blood donation centers,
and denied any lifetime history of schizophrenia. For each subject in the ICCSS, all four
grandparents were born in Ireland or the United Kingdom.
Results: Number of births in each month was compared for schizophrenics in the ISHDSF and
general population controls, resulting in a chi square of 19.44 (p value ~ 0.054, 11 df).
Simulations revealed that, in some circumstances, power to detect genetic associations was
increased by restricting cases to those born in high-risk months. Analysis of data from the ICCSS
revealed that restricting cases to high-risk birth months increased the evidence for association for
three of six markers tested, two of which were associated with the gene FBXL21.
Conclusions: Birth in the months of March, April, or May appears to be associated with elevated
risk for schizophrenia in the ISHDSF. In attempting to find susceptibility loci for schizophrenia,
restricting genetic association analyses to schizophrenics born in high-risk months may result in
increased power to detect genetic association in some circumstances.
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Introduction

Background and significance:
Schizophrenia is a mental disorder characterized by abnormalities in the perception or expression
of reality. According to the Diagnostic and Statistical Manual[1], schizophrenia includes
characteristic symptoms, such as delusions, hallucinations, and/or grossly disorganized behavior;
social and/or occupational dysfunction below the level achieved prior to onset of symptoms; and
a duration of at least six months (see Box 1). Although the course of schizophrenia may be
marked by varying degrees of recovery, complete cures are uncommon. The average duration
that an individual lives with schizophrenia is approximately 30 years[2]. The toll of
schizophrenia on patients and their families is considerable. Affected individuals have a 10 year
reduction in life expectancy[3], mostly an effect of increased rates of suicide. Among the leading
causes of disability-adjusted life years, schizophrenia ranks 8th in 15-44 year olds[4].
Schizophrenia is a relatively common disease. The point prevalence has been estimated at 4.6 per
1000 persons (80% confidence intervals 1.9-10)[5]. The incidence has been estimated as 15.2 per
100,000 persons per year (80% confidence intervals 8-43)[6]. Lifetime risk of schizophrenia is
estimated to be 0.7%[5].

Research to identify the causes of schizophrenia has been an active area of investigation for
decades. Although much has been learned, a recent survey of findings over the last 20 years
concluded, "what we can confidently assert is essentially the same -- both genetic and
environmental factors are important, but exactly which specific exposures and exactly how they
cause schizophrenia is still unknown…”[2]. Family history of schizophrenia is a risk factor. The
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relative risk associated with a positive family history depends on how closely related the affected
relative is to the person at risk. Having a monozygotic twin with schizophrenia equates to a
relative risk (RR) of 50-70, a first degree relative (e.g., a sibling) to a RR of 9-18, and a second
degree relative to a RR of 3-6[2]. At least some of the familial risk is a consequence of specific
genetic variants; dozens of loci within the human genome have been identified as putative
schizophrenia susceptibility loci, although the number of replicated findings is much smaller[7].
The RR associated with any specific single gene variant is 1.1-1.5[2]. Non-genetic risk factors
for schizophrenia include living in an urban environment (RR 2-3), history of migration (RR 23), and use of certain illicit drugs (RR 2-3)[2].

Another putative non-genetic risk factor for schizophrenia is season of birth. Tramer first made
the observation that among 3100 patients diagnosed with “psychosis”, there were 15% excess
births in winter-spring months (cited in [8]). Since then, many researchers have attempted to
replicate this finding. The most extensive single review of all these studies was that conducted by
Torrey et al, in 1997[8]. These authors reviewed > 250 articles, spanning 34 countries in both the
Northern and Southern Hemispheres and nearly 80 years of accumulated research. Even in the
face of methodological inconsistencies and other shortcomings, the authors concluded that the
studies were remarkably consistent in demonstrating a small, but significant, winter-spring birth
excess among schizophrenics. A more recent systematic review and meta-analysis of Northern
Hemisphere season of birth studies found a significant excess of winter/spring births compared
to summer/autumn (pooled odds ratio 1.07)[9]. More recent articles from Japan[10], Poland[11],
and Puerto Rico[12] have provided additional evidence to support an excess of schizophrenic
births in winter-spring.
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There are several prior studies that have addressed whether season of birth is a risk factor for
schizophrenia using samples from Ireland. O’Hare et al.[13] found 11% excess births for the
second quarter of the year in 4855 inpatients born between 1921 and 1955. O’Callaghan et
al.[14] examined 3253 persons with schizophrenia ascertained by case registers and found a 5%
excess of births from the first quarter, although the results were non-significant. Significant
results were found in this same study when subjects were restricted to individuals living in urban
environments. O’Callaghan et al.[15] examined 616 inpatients from 1983-1988 and found a 9%
excess of schizophrenia births for the first quarter, which was not statistically significant. This
last study further examined results from two patient subsets: those with a first-degree relative
affected by schizophrenia and those without. Season of birth and schizophrenia were found to be
significantly associated only in those individuals without a family history. Similar findings have
been reported in other, non-Irish samples[16], although other researchers have found evidence
for a season of birth effect even in individuals with a family history[17]. Hettema et al. found no
relationship between degree of familial vulnerability to schizophrenia and season of birth in an
Irish family study[18]. King et al.[19] studied a combination of 184 schizophrenic patients and
60 with affective disorder from Northern Ireland and found excess schizophrenia births in
March, April, and May.

On balance then, one could reasonably conclude that 1) in most studies, season of birth does
account for a small but significant risk for schizophrenia, 2) two of four studies using Irish
samples found a significant association between season of birth and schizophrenia, 3) all but
one[19] of the studies using Irish samples were limited to examining schizophrenia and quarter
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of birth, as opposed to month of birth, and 3) there is conflicting evidence as to whether
association of season of birth and schizophrenia is limited to those without a family history.

If season of birth is associated with risk for schizophrenia, what exactly does this mean? How are
the two related? The most probable explanation is that season of birth is a proxy variable for
some unmeasured, seasonally varying environmental factor that influences risk in prenatal or
early neonatal life; possibilities include meteorological variables such as temperature and light,
maternal infections during pregnancy (e.g., influenza, rubella, etc.), and malnutrition[20]. The
action of such a risk factor would disrupt the normal maturation of the brain in prenatal and early
neonatal life, a concept known as the neurodevelopmental hypothesis[21]. Seasonal variation in
exposure to this unmeasured environmental risk factor combined with vulnerability only during
prenatal or early neonatal life would translate into the observed excess of schizophrenic births at
certain times of the year.

Individual human genetic variation is thought to be an important determinant of the response to
various environmental exposures, including infections[22] and nutrition[23]. Thus, it is not
unreasonable to expect that genetic and environmental factors might also interact to produce risk
for psychiatric disorders, including schizophrenia. This concept is supported by the observation
that schizophrenia is known to be associated with various environmental factors (see above), but
there is apparently considerable variation in individual response to these environments[24]. In
fact, indirect evidence that gene-environment interactions influence risk for schizophrenia has
already been adduced, using proxy genetic variables (e.g., positive family history) and
environments (reviewed in [24]). In the case of season of birth and schizophrenia, this concept
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translates to the hypothesis that different individuals react differently to the exposure indexed by
season of birth, depending on their genotype. This particular type of gene-environment
interaction is also known as “genetic control of sensitivity to the environment[25].” For example,
in the case of maternal infections, this hypothesis would state that certain individuals have
genotypes that make them quite vulnerable to the effect of maternal infections during their in
utero development, while other individuals with different genotypes are relatively invulnerable.
In this scenario, the combination of the “wrong” genotype with a “bad” season of birth--a proxy
for the likelihood of maternal infection during a critical period of pregnancy--would increase risk
for schizophrenia beyond that expected from simply adding the risks of the two factors.

If gene-environment interaction of the type discussed above does underlie the apparent
relationship of schizophrenia and season of birth, might this suggest an alternative approach to
detecting susceptibility loci? In gene association studies, one typically compares genotype
frequencies in a set of cases and controls. If differences are found, this is taken as evidence that
gene variants at that locus may confer risk for the phenotype under study. Alternatively, one
could restrict the set of schizophrenics to those exposed to the environmental risk factor, i.e.,
those born in high-risk months. Such an approach would necessarily result in a reduced sample
size, since only the exposed cases would be included. However, the loss of power associated
with a smaller sample could potentially be more than offset by a gain in power due to increased
effect size in a more homogenous subgroup, as would be the case if genotype and phenotype
were more strongly associated in exposed individuals. This leads to the following question:
under what specific conditions, i.e., combination of sample size, effect size, etc., does use of
exposed cases only result in increased overall power to detect genetic associations? Further,
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which variables are most important in determining power? Finally, could such an approach
actually result in increased evidence for genetic association when applied to real data?

Objectives
1) The Irish Study of High Density Schizophrenia Families (ISHDSF) is a study of high-density
schizophrenia families from Ireland and Northern Ireland. This sample has not previously been
examined for evidence of excess schizophrenic births in winter-spring. Dates of birth are
recorded for nearly all individuals in the sample. Because of the inclusion criteria, schizophrenic
individuals in this sample represent familial, as opposed to sporadic, cases of schizophrenia.
Given the findings from the literature above, it is of interest to examine whether there is an
excess of schizophrenic births in winter-spring months in this sample, especially in light of the
controversy as to whether the schizophrenia-season of birth relationship is confined to nonfamilial cases. Also, monthly birth figures for the general population of Ireland were obtained for
use as controls. It is of interest to analyze the data by month, since most previous studies of Irish
samples categorized birth by quarter. For these reasons, the first objective of this work is to
determine whether season of birth differs between schizophrenics from the ISHDSF and general
population controls by month and also by quarter.

2) As discussed above, the most powerful analytic strategy to detecting genetic associations with
schizophrenia, assuming gene-environment interaction, is unclear. However, the most powerful
strategy will likely depend on specific parameters such as sample size, gene effect size, etc.
Computer simulations, incorporating pre-specified event probabilities, can be extremely valuable
in uncovering general trends and important factors that determine the power of a given statistical
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test. For these reasons, the second objective of this study is to examine, by computer simulation,
power to detect the association of a susceptibility locus and schizophrenia under a variety of
assumptions, including different models for the interaction of genetic risk and season of birth in
determining schizophrenia. It is of particular interest to compare analyses using all cases, and
analyses using cases only born in high-risk months.

3) The Irish Case Control Schizophrenia Study (ICCSS) is a case-control study designed to
identify genetic loci associated with schizophrenia. Genotypes at multiple marker loci are
available for individuals in this sample. Birthdates are available for schizophrenics in the sample.
The third objective of this study is to examine six markers for evidence of association to
schizophrenia using the two analytic strategies explored in the simulations above, i.e., with all
cases and then with cases born in high-risk months. This is meant primarily to illustrate the
analytic strategies employed in the simulations using actual, real-world data.
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Methods

Season of birth and risk for schizophrenia in Ireland

Design: This case-control study was conducted using the Irish Study of High Density
Schizophrenia Families (ISHDSF) to identify cases, and the general population of Ireland, as
provided by Ireland’s Central Statistics Office (CSO), as controls. It was assumed that the
prevalence of schizophrenia in the entire population of Ireland is low enough so that, any
relationship that may exist between schizophrenia and season of birth would have little or no
effect on statistics calculated using the general population as controls. General population data
have been used previously as controls in studies of season of birth and schizophrenia[26].

The study hypothesis was that an excess of schizophrenic births exists in winter-spring months.
This study tested this hypothesis by comparing birth frequencies, by month and by quarter, in
schizophrenic cases to expected values based on general population controls.

Sample and Data Collection: The source of cases, the ISHDSF, has been described in detail
elsewhere[27]. Fieldwork for this study was completed between April, 1987 and November,
1992. The sample was initially conceived for the purposes of genome-wide searches for
schizophrenia susceptibility loci. Prior research had indicated that, while genetic factors are a
major part of an individual’s risk for schizophrenia, their mode of transmission is complex[28].
The genetic architecture of schizophrenia is consistent with either 1) different genes of major
effect across different families or 2) multiple, relatively common genes, each with a smaller
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effect on vulnerability[27]. Because of this, detection of schizophrenia susceptibility loci was
expected to require large numbers of families, ascertained according to standardized procedures.
The ISHDSF was designed to accomplish these goals.

Families were ascertained through 39 in-patient psychiatric care facilities serving over 95% of
the population of Ireland and Northern Ireland. Hospital records and personal interviews with
facility staff (including psychiatrists, nurses, and medical record librarians) were used to identify
families with at least two individuals who might have psychotic illness. Approximately 1000
families identified in this way were subjected to an initial screening. The field criterion for
follow-up and exhaustive study was families with two or more first-, second-, or third- degree
relatives who, according to the field psychiatrist, met DSM-III-R criteria for schizophrenia or
poor-outcome schizoaffective disorder (PO-SAD). No exclusion criteria were used. This meant
for example, a family might be included that met entry criteria, but also had individuals with
alcohol dependence or major depression. The decision to include PO-SAD as a possible
inclusion criterion was based on results from family and adoption studies suggesting a common
genetic basis for this condition and schizophrenia[29, 30].

From families who met the above preliminary screening criteria, an individual was contacted to
provide a family pedigree and also to help decide which family members would be interviewed
and sampled for DNA. General rules for these decisions included the following: 1) sample all
affected individuals, 2) sample all “connecting” individuals situated between affecteds within the
family pedigree, 3) sample all first-degree relatives of affecteds ages 16 and above, and 4) if a
key individual is unaffected but cannot be sampled, attempt to sample up to 3 siblings.
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Attempts were made to personally interview all traceable and cooperative family members
residing in Ireland, Northern Ireland, or cities in England. The study authors estimate they
interviewed 88% of traceable living probands and 86% of traceable living relatives.

The field team consisted of psychiatrists and social scientists with experience in mental health or
surveys. Whenever possible, a psychiatrist interviewed individuals with suspected psychosis,
while social scientists generally interviewed unaffected individuals. Thus, interviewers were not
blind to the probable history of psychopathology in interviewees.

The assessment instrument was a modified version of the Structured Interview for DSM-III-R
Diagnosis (SCID)[31] for selected disorders including major depression, psychosis and mania;
and the Structured Interview for Schizotypy (SIS)[32] for schizophrenia spectrum personality
disorders. In almost all cases of schizophrenia or schizoaffective disorder (98.6%), psychiatric
in-patient records were obtained and abstracted, as well. Two psychiatrists blinded to pedigree
and genotype data then reviewed all available diagnostic information. Diagnostic agreement was
excellent with a kappa of 0.94.

On the basis of the best available information from twin and adoption studies, several diagnostic
categories were defined for this study, which were intended to reflect the underlying relationship
of the various conditions[33]. The definitions of affection were: 1) narrow, to capture “core
schizophrenia phenotypes”, 2) intermediate, which in addition to those meeting narrow criteria
included individuals with schizotypal personality disorder and all other nonaffective psychotic
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disorders, 3) broad, including all the previous, plus individuals with psychotic affective disorders
and paranoid, avoidant, and/or schizoid personality disorders. Final inclusion criteria for the
ISHDSF used the above diagnostic classification and can be stated as follows: include families
with two or more affected first-, second-, or third-degree relatives with an intermediate
diagnosis, one or more of whom also met criteria for a narrow diagnosis. The birth month and
year were recorded for all individuals in the sample. The final sample included 277 pedigrees
with 1,770 individuals. Using the intermediate definition of affected, the sample included 837
affected individuals. Approximately 67% were male and the average age at the time of
evaluation was 45.9 years. For the purposes of this study, cases were defined by the intermediate
set of criteria described above. Cases defined using the other criteria were also examined, but
results were essentially the same as those discussed below.

There are at least two methodological limitations of the ISHDSF that may be relevant to the
present study. First, the sample is not truly an “epidemiologic” sample, since ascertainment
depended partly on the recollections of health care professionals. Second, interviewers were not
blind to knowledge of psychopathology in the subject’s relatives. Interviewers were repeatedly
cautioned to discount any such knowledge during their clinical assessments, but this is a
potential source of bias from the diagnostic phase of the ISHDSF.

The affected individuals from the ISHDSF constituted the sample of cases. Controls were from
the general population of Ireland. Information on numbers of births for each month was obtained
from the Central Statistics Office (CSO) of Ireland, covering the years 1976-2000. General
population births by quarter were obtained for the years 1900-2000. One unavoidable limitation
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of the available data is that the range of birth years for the general population was different from
that of the cases, when using birth month data. This was the reason for also examining births by
quarter.

By using general population numbers to form the control sample, some individuals with
schizophrenia were inevitably included as ‘controls’. It was assumed that the prevalence of
schizophrenia in the general population was low enough so that this effect was negligible to a
first approximation.

Testing for an association between season of birth and schizophrenia: Information on cases was
taken from the ISHDSF, as described above. Information on controls was taken from the Irish
CSO, as described. A chi square test was used to determine whether there was a difference
between the monthly birth frequencies in the schizophrenic and control groups. Expected
numbers of births for each month were derived by multiplying the observed monthly birth
frequencies for control patients by the total number of schizophrenic patients. The list of
observed and expected numbers of monthly schizophrenic births were compared using a chi
square test with 11 degrees of freedom.

For each month, the average daily birth frequency was calculated for both groups as follows.
First, the fraction of the total group born in a given month was calculated as the count of
individuals born in that month divided by the number of individuals in the group. Next, the
average daily birth frequency was determined by dividing the fraction born in that month by the
number of days in the month. For February, the number of days used was 28.25, to
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approximately account for the effect of leap years. This daily birth frequency was graphically
plotted to directly compare trends across the year for both groups.

Power Simulations

Design: The gene-environment interaction hypothesis discussed above (see Introduction) raises
several questions. Under such a hypothesis, is there any justification for altering the standard
approach to searching for disease susceptibility loci? Specifically, in a case-control study
designed to test for an association between genotype and schizophrenia, is there any justification
for restricting the sample of schizophrenics to those born only in "bad" (i.e. winter-spring)
months? Such an approach would necessarily lead to a smaller sample size. However, it is
conceivable that the loss of power associated with this could be more than offset by a gain in
power due to a more homogenous set of cases. What factors are most critical in determining
power to detect genetic associations, assuming gene-environment interaction? In order to gain
insight into these questions, Monte Carlo computer simulations were conducted to examine
power to detect genetic association under a variety of plausible scenarios and using two different
analytic approaches.

These computer simulations all followed the same basic steps: 1) simulate a set of cases and
controls, including genotypes and month of birth for each individual, 2) using the genotypes and
month of birth, simulate phenotype (i.e., schizophrenia or not) for each individual, 3) conduct a
statistical test of association using the simulated case-control data, and record the resulting pvalue.
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For each set of simulation conditions, these three steps were repeated until 1000 tests of
association had been conducted. Power to detect association for a given set of conditions was
defined as the fraction of the 1000 statistical tests of association with p-values < 0.05.

All simulations were scripted using Python, version 2.5.1, which includes a pseudo-random
number generating module. The effect of several variables on power to detect genetic
associations with schizophrenia was evaluated by simulating data sets assuming different sets of
conditions. A condition was defined as one particular combination of sample size, gene effect
size, minor allele frequency, and phenotype model (each defined below). A total of 8 conditions
were simulated (see Table 1) and each was analyzed using two different approaches, giving a
total of 16 estimates of power.

Simulation conditions and procedures: Sample size was either 1000 cases and 1000 controls, or
500 cases and 500 controls. Minor allele frequency (MIF), which here refers to the population
frequency of the disease allele, was set to either 0.2 or 0.3, consistent with observed MIFs for
many human single nucleotide polymorphisms[34]. Genotype for an individual was simulated by
randomly choosing two alleles independently, according to the MIF.

As noted above, month of birth and was also simulated for all individuals. To simulate month of
birth, an equal probability of being born on any day of the year was assumed. A cumulative
probability distribution was constructed to reflect the probability of being born in January,
February, March, etc. For all months except February, the probability of being born in that
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month was simply the number of days in the month divided by 365. For the month of February,
the number of days was set equal to 28.25, to include the effect of leap years. Thus, the
probability of being born in February was set as 28.25 divided by 365. Month of birth for an
individual was simulated by randomly choosing a month according to this probability
distribution.

Once month of birth and genotype were simulated for a given individual, these were combined
using a probabilistic model, model1, to determine phenotype:

probability of disease = 0.01 + (number of disease alleles)*(effect size) + (bad month)*(number
of disease alleles)*(effect size)

Here, “disease” refers to schizophrenia. All individuals were assumed to have a baseline risk of
schizophrenia of 0.01 (approximately equal to the lifetime prevalence of schizophrenia[35]),
independent of their month of birth and their genotype at the susceptibility locus. In addition,
each disease allele conferred a specific amount of risk. This was termed the gene's effect size;
effect sizes used for model1 were 0.001 and 0.002. March, April and May were designated as
high-risk birth months (see Results, below). A binary variable called "bad month" was created
that took a value of 1 for individuals born in March, April, or May and a value of zero for
individuals born in other months. All of these variables were then combined using the equation
for model1 to produce a probability of disease.

As an example of the use of model1, consider a simulated individual with one disease allele
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(genotype Aa, with 'a' standing for the disease allele) and born in the month of December (thus
"bad month" = 0) with a gene effect size of 0.002. The probability of this person having
schizophrenia by model1 would then be:

0.01 + (1)*(0.002) + (0)*(1)*(0.002) = 0.012

The phenotype in this case would be determined by randomly drawing a number between 0 and 1
(all numbers equally likely); if the number were less than or equal to 0.012, this individual would
have schizophrenia, otherwise not. Such individuals were simulated until the specified numbers
of cases and controls were reached.

We also investigated a variation of this model (model2), where the susceptibility locus only
conferred risk on those individuals born in high-risk months. This alternate model for phenotype
developement can be expressed as:

probability of disease = 0.01 + (bad month)*(number of disease alleles)*(effect size)

Note that, in this model, there is no elevated risk associated with the disease allele in individuals
who are born in "good" months. The effect sizes used in this model were 0.002 and 0.004; these
numbers were different from those used in model1. This was done so that individuals in the
highest risk category (two disease alleles and born in a bad month) would have the same risk in
model1 and model2. Note that both model1 and model2 are probabilistic. This means that the
simulated phenotype for an individual with two disease alleles could be "normal," and
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conversely, that the simulated phenotype for an individual with no disease alleles could be
"schizophrenia."

Analysis of simulated data: Once the specified numbers of cases and controls were simulated, the
entire simulated data set was analyzed to test for any evidence of association between genotype
and phenotype. Two separate chi square tests were conducted for each set of simulated data. In
the first, the observed genotype frequencies across all cases were compared to the expected
frequencies based on the controls. In the second test, the observed genotype frequencies in the
subset of cases born in “bad” months (March, April, or May) were compared to the expected
frequencies. This second test represents an alternative approach to searching for susceptibility
loci. Again, the primary purpose of these simulations was to determine if there was any rationale
for choosing this second approach over, or at least in addition to, the standard approach (using
the entire set of cases and controls). That is, are there circumstances when using only a subset of
the cases would actually result in a gain in power to detect genetic associations?

Analysis of the Irish Case Control Study of Schizophrenia

Design: As an illustration of the analytic approach used in the power simulations, and to test the
hypothesis that gene-season of birth interaction influences risk for schizophrenia, data from the
Irish Case Control Study of Schizophrenia were analyzed (ICCSS). The ICCSS is a sample of
schizophrenic and control subjects with genotypes available for several loci within the genome.
The strategy employed for this study was to 1) select genotyped loci from individuals in the
ICCSS, and 2) analyze these loci for evidence of association with schizophrenia using all cases,
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and then using only cases born in March, April, or May. This is exactly the analytic strategy
employed in the simulations; the main purpose here was to use this strategy with real data.

Sample: The ICCSS is a sample of schizophrenic and control individuals from Ireland and
Northern Ireland, i.e., the same geographic areas as the ISHDSF. Cases were selected from inand outpatient psychiatric facilities. To be eligible for enrollment, cases had to meet DSM-III-R
criteria for schizophrenia or schizoaffective disorder with poor outcome. A blinded, expert
reviewer verified all diagnoses. Controls were selected from several sources, including blood
donation centers. Controls were eligible if they denied a lifetime history of schizophrenia.
Potential subjects were included only if all four of their grandparents were born in Ireland or the
United Kingdom. The number of cases and controls with complete data, and thus used in these
analyses, varied depending on the marker, but there were approximately 700 cases and 600
controls.

Marker selection and genotyping: A set of six previously genotyped markers for cases and
controls was selected for this study. All markers were single nucleotide polymorphisms (SNPs)
within or near genes one of three genes: IL3, FBXL21, and CSF2RB. The SNPs included in this
analysis are shown in Table 2, along with the names and descriptions of genes they occur in or
near.

As noted above, all markers selected for analysis in this study were previously genotyped and
analyzed, and details of marker genotyping have been described[36]. Briefly, HapMap data and
existing assays developed by Applied BioSystems were used to select markers. SNPs were
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selected only if they covered haplotypes with population frequencies > 1%. Genotyping was
done using the TaqMan method. Genotypes were scored, and all SNPs were checked for
deviations from Hardy Weinberg equilibrium and for Mendelian consistency.

Statistical Analyses: A chi square test was used to evaluate whether there was any evidence for
genetic association at each of the markers. For each SNP, the genotype frequencies were derived
for cases and controls. Expected genotype frequencies were derived using control genotype
frequencies. Observed genotype frequencies were defined as those observed for the cases. For
each SNP, a chi square test was performed using all cases, and then a second test was performed
using only those cases born in March, April, or May. The reason for choosing these specific
months was that excess schizophrenic births were observed in these months using the ISHDSF
(see results, Season of birth and schizophrenia in the ISHDSF, below). All controls were used for
each test. All analyses excluded any cases with missing birthdates or genotypes, and any controls
missing genotypes.
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Results

Season of birth and schizophrenia in the ISHDSF

The first part of this studied aimed to determine whether there is evidence that season of birth
influences risk for schizophrenia using cases from the ISHDSF and general population controls.
Table 3 shows, for each month of birth, the observed counts of cases and controls, as well as the
expected number of cases based on the observed control frequencies. Comparing the observed
and expected counts for cases gave a chi square value of 19.44 (p-value 0.054, 11 df). Note that
data on month of birth were available for controls only for the years 1976-2000. The years of
birth for the cases, however, ranged from 1893-1973.

Table 4 shows, for each quarter of birth (quarter 1 including January, February, or March as the
month of birth; quarter 2 including April, May, or June; etc.), the observed counts of cases and
controls, as well as the expected number of cases based on the observed control frequencies.
Comparing the observed and expected counts for cases gave a chi square value of 7.48 (p-value
0.058, 3 df). Here, data on quarter of birth for controls was available for the years 1900-2000.

In order to examine the data visually for any possible trends, data for cases and controls were
plotted together. Figure 1 shows daily birth frequency by month for cases and controls. Daily
birth frequency is the fraction of births in a given month divided by the number of days in that
month. This measure was used so that cases and controls would be on a comparable scale, and so
that the effect of months with differing lengths would be removed. The figure indicates a trend
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toward excess of schizophrenic births in the months of March, April, and May, and also an
apparent birth deficit in the months of August, September, and October. Figure 2 similarly shows
the daily birth frequency by quarter for cases and controls. Note that the quarters, as defined by
the calendar, split the months of excess birth (March in quarter 1, April and May in quarter 2).
Still, there seems to be an excess of schizophrenic births in the first two quarters and a
concomitant deficit in the second two quarters. As before, month of birth is available for controls
covering 1976-2000; quarter of birth is available for controls covering 1900-2000.

As noted in Methods, the ISHDSF had several diagnostic categories for schizophrenia, ranging
from narrowly-defined schizophrenia to a much broader phenotype including categories such as
paranoid, avoidant and schizoid personality disorder; mood incongruent and mood congruent
psychotic affective illness; and delusional disorder. The analyses above were repeated with each
diagnostic category. The trends observed were essentially the same as those shown, with excess
schizophrenic births in March, April, and May. The lowest p-value (0.014) was for a broad
definition of affection, which included schizophrenia, poor-outcome schizoaffective disorder,
simple schizophrenia, schizotypal personality disorder, schizophreniform disorder, delusional
disorder, atypical psychosis, good-outcome schizoaffective disorder, psychotic affective illness,
and paranoid, avoidant, and schizoid personality disorders.

Power simulations

The second part of this study was designed to explore the power to detect genetic associations
under a variety of plausible hypotheses regarding how genes and season of birth might interact to
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produce risk for schizophrenia. Table 5 shows the results of the power simulations using model1,
i.e., where the susceptibility locus increases risk for schizophrenia in all months of birth, but
more so for March, April, and May. For analyses with all cases and all controls, power ranges
from 42% to 96%. The most significant gains in power appear to be associated with increasing
gene effect size (e.g. with 500 cases/controls and MIF = 0.2, power increases from 42% to 72%
as the gene effect size increases from 0.001 to 0.002). For analyses that restrict cases to those
born in March, April, and May, power is always less than the corresponding conditions using the
entire set of cases. When cases are restricted to "bad" birth months, power to detect genetic
association ranges from 25% to 85%. As with analyses using the full set of data, the most
marked jumps in power are associated with increased gene effect size.

Table 6 shows the results of the power simulations using model2, i.e., where the susceptibility
locus increases risk for schizophrenia only among those born in March, April, or May. The most
marked difference from the simulations using model1 (Table 5) is that power to detect genetic
association is almost always greater for the analyses using cases restricted to "bad" birth months.
For example, with 1000 cases/controls, a gene effect size of 0.004, and MIF = 0.2, power is 82%
for when cases are restricted, while power is 48% using all cases. For analyses with all cases and
all controls, power ranges from 28% to 51%. For analyses with cases restricted to those born in
bad months, power ranges from 29% to 87%. When the gene effect size was 0.002, power using
the restricted set of cases was approximately equal to the power using all cases with 500
cases/controls. The difference between the two analytic strategies was substantially greater for a
gene effect size of 0.004.
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Analysis of the Irish Case Control Study of Schizophrenia

Table 7 contains the results of the analysis of six SNPs for evidence of association with
schizophrenia using the ICCSS. Significant evidence of association (p < 0.05) was found using
all cases for markers rs2284031, rs909486, and rs31555. Significant evidence of association
using the subset of cases born in March, April, and May was found for only one SNP, rs31555.
Restricting cases to the specified birth months resulted in three instances of an increased chi
square value (decreased p-value), for SNPs rs1859427, rs31555, and rs3914025. In one of these
instances (rs31555), the p-value decreased from ~0.038 to ~0.011, even though the number of
cases decreased from 692 to 173.
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Discussion

This multi-part study sought to explore, from several perspectives, season of birth as a potential
risk factor for schizophrenia. First, this study examined whether there was evidence to suggest
that months of birth are different in schizophrenics from the ISHDSF vs. the Irish general
population using a case-control design. Second, power simulations were conducted to compare
different analytic strategies given different parameter values and assumptions about the
interaction of genetics and season of birth to produce risk for schizophrenia. Third, actual genetic
data from the ICCSS were analyzed using the strategies studied as part of the simulations.

The first part of this study used a case-control design. Cases were individuals diagnosed with
schizophrenia from the ISHDSF. Controls were the general population of Ireland. The chi square
test of whether months of birth differed between cases and controls was marginally significant
(p-value 0.054). Visual inspection of the data revealed a trend toward increased schizophrenic
births in March, April, and May. Taken together, these results suggest that season of birth is a
risk factor for schizophrenia for cases in the ISHDSF. The chi square test is relatively insensitive
to a positive finding for the following reason: it does not take into account the expected monthto-month correlations in birth rates[17]. More specifically, if birth rate truly does change over the
course of the year, it would be expected to gradually rise and fall, as opposed to suddenly rising
in one month, falling in the next, etc. The insensitivity of the chi square test to these different
possibilities can be understood by considering the following: randomly shuffling months, so that
an implausibly jagged rise and fall of schizophrenic birth rates were observed, would give the
same chi square value. Thus, a better statistical test would be one that accounted for the expected
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inter-month correlations of birth rates. Moreover, while it is certainly possible that any individual
month with an excess of schizophrenic births could be a random occurrence, the random
consecutive occurrence of excess births across three months is much less likely. Thus, it seems
reasonable to conclude that season of birth is different for schizophrenics and controls, with an
excess of schizophrenic births in the winter-spring months of March, April, and May. It is
interesting that such an effect was observed in light of two previous findings: 1) power analyses
which suggest that thousands of subjects are necessary for a reasonable chance at detecting a
season of birth effect[37], and 2) findings which suggest that excess winter-spring schizophrenic
births are limited to cases without a family history[15].

The case-control approach used above is subject to a number of limitations. First, the control
data were taken from aggregate population-level data provided by the Irish CSO. The only
information available was the total number of individuals born in Ireland by month for each year
from 1976 to 2000, and by quarter from 1900 to 2000. Since this is data for the entire population,
it is reasonable to suppose that the number of females is approximately equal to the number of
males, and obviously, chronological ages can be determined. Other potential schizophrenia
covariates are, however, unavailable. As discussed above, increased risk associated with season
of birth is thought to be a proxy for maternal infection or some other seasonally varying toxic
environmental exposure. A direct measure of any of these putative factors would be desirable,
since one could directly test whether the factor accounts for the observed relationship between
season of birth and schizophrenia. Studies of this kind have been conducted[38], but are
generally difficult because of time and resource constraints.
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Second, we had to assume that the individuals represented by the aggregate population data were
not schizophrenic. Because the prevalence of schizophrenia is approximately 1%, this is a
reasonable first approximation. The effect of including some schizophrenics in the set of controls
should, in fact, make detection of an association between season of birth and schizophrenia more
difficult, since such a misclassification would tend to make the control and schizophrenic groups
more similar. This design, with general population controls, has been used previously to study
schizophrenia and season of birth[26].

Third, for the month-to-month analysis in Figure 1, the controls were born over a different range
of years as compared to the schizophrenics. It was assumed that monthly birth frequencies would
not vary across time, i.e., that the observed monthly birth frequencies would be the same for a
control group drawn from the same range of birth years as the schizophrenic group. To more
directly test this assumption, quarter of birth and schizophrenia were examined using the same
set of ISHDSF cases and CSO Irish controls born between 1900 and 2000. As shown in Figure 2,
the ranges of birth years for the cases and controls still do not exactly match, but the ranges are
more closely matched than for the analysis by month. The analysis by quarter produced
essentially the same result as the first: a marginally significant p-value (0.058) and a trend
toward increased schizophrenic births in quarters 1 and 2 (see Figure 2).

The power simulations involved two distinct models for how genes and season of birth could
combine to determine risk for schizophrenia. In the first, model1, the susceptibility gene
increased risk for all individuals, but more so for those born in months 3-5. In the second,
model2, the susceptibility gene only increased risk for individuals born in months 3-5, but not at
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all for individuals born in other months. Under model1, there was greater power to detect genetic
associations when all cases are used in the analysis. Under model2, there was generally more
power to detect genetic associations when the pool of cases is restricted to those individuals born
in months 3-5. This is in spite of the fact that such restriction decreased sample size. Such a
finding suggests that in actual studies of genetic association, restricting the set of cases may
increase the likelihood of detecting true positive associations. Since the only additional data
required for such an analysis would be season of birth, it should be relatively easy to implement.
As always, the number of tests should influence one's interpretation of the resulting p-values, and
statistical correction for multiple testing is advisable[39]. As with any set of computer
simulations, the conclusions from these simulations are, strictly speaking, only applicable to the
conditions studied. Furthermore, this approach requires assumptions regarding the relationship of
genotype and phenotype, MIF, and gene effect size. Care was taken to ensure that the values
used for the simulation conditions were plausible[2, 34].

Based on the findings of the power simulations, data on 6 SNP markers from the ICCSS were
analyzed using all cases, and then using cases born in months 3-5. In one of six cases, an initially
significant result became more significant when cases were restricted to bad months of birth (for
SNP rs31555). As shown in Table 2, this SNP is associated with the gene FBXL21, an F-box
containing protein that functions in ubiquitin-mediated proteolysis. The results for the other SNP
associated with this gene, rs1859427, were nonsignificant, however, the p-value did decrease
from 0.342 to 0.175. Thus, restriction of cases was associated with larger chi square values for
both SNPs associated with this gene. There was one other marker that showed an increased chi
square value with the restricted set of cases, marker rs3914025 associated with the IL3 gene. The
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other maker associated with IL3 and the two remaining markers all had decreased chi square
values with the restricted set of cases. Findings of genetic association are often plagued by failed
attempts at replication. Thus, these results should be interpreted with a great deal of caution and
skepticism. However, these tests do serve as a general illustration of the procedure suggested by
the simulations above.

In all the tests for genetic association, all controls were used, regardless of whether the cases
were restricted by month of birth or not. The validity of this procedure requires the following
assumption: genotype frequencies are the same across all months of birth for the control
individuals. Unfortunately, it is not possible to directly test this assumption, since the only
information available for most controls was their genotype and the fact that they denied any
history of schizophrenia. It is conceivable that this assumption is false, i.e., certain genotypes
combined with certain months of birth lead to increased overall mortality in the general
population, perhaps via maternal infections.
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Conclusion

In summary, this examination of season of birth and schizophrenia suggests that birth in the
months of March, April, or May is associated with increased risk for schizophrenia, even in
individuals with highly familial schizophrenia. The power simulations demonstrate that power to
detect genetic associations may be increased by restricting cases of schizophrenia to those born
in months of elevated risk. Specifically, this was the case when a susceptibility locus conferred
risk for schizophrenia among those born in high-risk months, but no risk to those born in other
months. Finally, analysis of six SNPs for genetic association revealed that for the gene FBXL21,
evidence for association was stronger when cases were restricted to those born in high-risk
months. For future work, investigators conducting genome-wide association studies for
schizophrenia susceptibility loci should consider using subject dates of birth as an
“environmental” risk factor, to probe for gene-environment interactions. Such an approach could
result in substantially increased power to detect susceptibility loci for schizophrenia.
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Tables
Box 1. DSM-III-R criteria for schizophrenia.
1. Characteristic symptoms: Two or more of the following, each present for much of the time
during a one-month period (or less, if symptoms remitted with treatment).
• Delusions
• Hallucinations
• Disorganized speech
• Grossly disorganized behavior (e.g., dressing inappropriately, crying frequently) or
catatonic behavior
• Negative symptoms—affective flattening (lack or decline in emotional response),
alogia (lack or decline in speech), or avolition (lack or decline in motivation)
If the delusions are judged to be bizarre, or hallucinations consist of hearing one voice
participating in a running commentary of the patient’s actions or of hearing two or more voices
conversing with each other, only that symptom is required above. The speech disorganization
criterion is only met if it is severe enough to substantially impair communication.
2. Social/occupational dysfunction: For a significant portion of the time since the onset of the
disturbance, one or more major areas of functioning such as work, interpersonal relations, ore
self-care, are markedly below the level achieved prior to the onset.
3. Duration: Continuous signs of the disturbance for at least six months. This six-month
period must include at least one month of symptoms (or less, if symptoms remitted with
treatment).

Table 1. Simulation conditions.
Parameter
Number of cases/controls

Values used in simulations
500/500
1000/1000

Gene effect sizes

For Model1: 0.001, 0.002
For Model2: 0.002, 0.004

Minor allele frequencies (MIFs)

0.2
0.3

Phenotype models

Model1: disease alleles confer risk for persons born in all
months, more risk if born in month 3, 4, or 5
Model2: disease alleles only confer risk for persons born
in months 3, 4, or 5.
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Table 2. Single nucleotide polymorphism (SNP) markers used in this study.
SNP
Associated gene Description of associated gene
rs1859427 FBXL21
F-box containing protein, functions in ubiquitin-mediated
protein breakdown
rs31555
FBXL21
F-box containing protein, functions in ubiquitin-mediated
protein breakdown
rs2069803 IL3
interleukin-3
rs3914025 IL3

interleukin-3

rs2284031 CSF2RB

shared subunit of receptors for IL3, CSF2, and IL5; initiates
signal transduction after ligand binding
shared subunit of receptors for IL3, CSF2, and IL5; initiates
signal transduction after ligand binding

rs909486

CSF2RB

Table 3. Observed and expected schizophrenia cases by month, using data from the ISHDSF and
general population controls from Ireland.
cases observed controls observed control frequencies
cases expected
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Total

65
56
79
72
78
56
66
46
54
43
50
55
720

123252
114937
130623
125996
131482
124114
128671
123970
125600
122764
115511
119140
1486060

0.082938778
0.077343445
0.087898874
0.084785271
0.088476912
0.083518835
0.086585333
0.083421935
0.084518795
0.082610393
0.077729701
0.080171729
1
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59.71591995
55.68728046
63.28718894
61.04539521
63.70337671
60.13356123
62.34143978
60.06379285
60.85353216
59.47948266
55.96538498
57.72364507
720

Table 4. Observed and expected schizophrenia cases by quarter, using data from the ISHDSF
and general population controls from Ireland.
cases observed controls observed control frequencies cases expected
Quarter 1
Quarter 2
Quarter 3
Quarter 4
Total

200
206
166
148
720

1726052
1822911
1741833
1619132
6909928

0.249793051
0.263810419
0.252076867
0.234319663
1

179.850997
189.9435016
181.4953441
168.7101573
720

Table 5. Results of power simulations using model1, i.e., disease allele confers risk on all
persons, but more risk on persons born in months 3, 4, or 5. Results for analyses with all cases
and with cases restricted to those born in high-risk months are shown.
number of
gene effect size minor allele
power: all cases power: only
cases, controls
frequency
cases born in
mo 3-5
500
0.001
0.2
0.424
0.252
0.3
0.45
0.294
0.002
0.2
0.723
0.541
0.3
0.771
0.625
1000
0.001
0.2
0.56
0.36
0.3
0.626
0.443
0.002
0.2
0.915
0.807
0.3
0.957
0.848

Table 6. Results of power simulations using model2, i.e., disease allele confers risk only on
persons born in months 3, 4, or 5. Results for analyses with all cases and with cases restricted to
those born in high-risk months are shown.
number of
gene effect size minor allele
power: all cases power: only
cases, controls
frequency
cases born in
mo 3-5
500
0.002
0.2
0.277
0.289
0.3
0.279
0.276
0.004
0.2
0.344
0.575
0.3
0.375
0.617
1000
0.002
0.2
0.308
0.381
0.3
0.33
0.428
0.004
0.2
0.479
0.82
0.3
0.513
0.874
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Table 7. Results of genetic association analyses with six single nucleotide polymorphism (SNP)
markers, including all cases and restricting cases to those born in March, April, or May.
SNP
Associated
Using all cases
Using cases born in March,
marker
gene
April, or May
Chi square
p-value
Chi square
p-value
rs2284031
CSF2RB
7.379289268 0.024980878 1.291983631 0.524142432
rs909486
CSF2RB
9.99247693
0.00676334
3.369596814
0.18548182
rs1859427
FBXL21
2.147428809 0.341736808 3.484086426 0.175162141
rs31555
FBXL21
6.538706984 0.038031006 8.967530259 0.011290822
rs2069803
IL3
3.977176475 0.136888543
2.41160953
0.299450915
rs3914025
IL3
2.607192431
0.27155347
4.287835042 0.117194829
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Figures
Figure 1. Daily birth frequency by month for ISHDSF cases and general population controls.

Figure 2. Daily birth frequency by quarter for ISHDSF cases and general population controls.
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Appendix. Python script for power simulations.
import random, stats
#these are the number of cases (=number of controls)...
sample_sizes = [1000, 500]
#these are effect sizes (see pheno_model below)...
effect_sizes = [0.002, 0.004]
#minor allele frequencies...
mifs = [0.2, 0.3]
#model for phenotype, based on number of disease alleles and season of
birth...
def pheno_model(dz, sob, effect_size):
return 0.01 + dz*(effect_size) + sob*(dz*(effect_size))
#model for phenotype, based on number of disease alleles and season of
birth...
def pheno_model2(dz, sob, effect_size):
return 0.01 + sob*(dz*(effect_size))

#bad_months = birth months associated with increased risk of schizophrenia...
bad_months = [3, 4, 5]
daysInYear = 365.0
#days in month; Feb is approximation, based on fact of leap years...
dim = [ 31, 28.25, 31, 30, 31, 30, 31, 31, 30, 31, 30, 31 ]
#create cumulative prob dist for birth month
cp = []
lb, ub = 0.0, 0.0
for m in dim:
lb = ub
ub = ub + (m/daysInYear)
cp.append((lb, min(ub, 1.0)))
#simulates number of disease alleles at a locus, given mif
def sim_genotype(mif):
r1 = random.random()
r2 = random.random()
g1, g2 = 0, 0
if r1 < mif:
g1 = 1
if r2 < mif:
g2 = 1
return g1 + g2
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#simulates a birth month according to the cumulative prob distribution
above...
def sim_bd(cp):
r = random.random()
for i, (lb, ub) in enumerate(cp):
if r > lb and r < ub:
return i + 1
break
#simulates phenotype, given number of dz alleles and whether person was born
in a 'bad month'...
def sim_pheno(dz, sob):
pheno = 0
r = random.random()
if dz == 0:
phenocut = 0.01
else:
phenocut = pheno_model2(dz, sob, effect_size)
if r < phenocut:
pheno = 1
return pheno
#:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
#simulations start here...
for n in sample_sizes:
for effect_size in effect_sizes:
for mif in mifs:
#make output file...
outputfilename = 'power3_' + str(n) + '_' + str(effect_size) + '_'
+ str(mif)
outfile = open(outputfilename, 'w')
#print sim parameters...
print >>outfile, 'number of cases (=number controls):', n
print >>outfile, 'effect size:', effect_size
print >>outfile, 'minor allele frequency:', mif
print >>outfile, 'phenotype model: 0.01 + dz*(effect_size) +
sob*(dz*(effect_size))'
print >>outfile, '\n'
#starting simulations...
ctsiggood, ctsigbad, ctsigsep, ctsig, cttotal = 0, 0, 0, 0, 0
for iter in range(1000):
#sim controls...
controls = []
while len(controls) < n:
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sob = 0
dz = sim_genotype(mif)
mo = sim_bd(cp)
if mo in bad_months:
sob = 1
pheno = sim_pheno(dz, sob)
if pheno == 0:
controls.append((dz, mo, sob, pheno))
#sim cases...
cases = []
while len(cases) < n:
sob = 0
dz = sim_genotype(mif)
mo = sim_bd(cp)
if mo in bad_months:
sob = 1
pheno = sim_pheno(dz, sob)
if pheno == 1:
cases.append((dz, mo, sob, pheno))
#keys are, for each category, number of bad disease alleles;
values are counts of people in that category with that number of dz alleles
countsCases_goodSOB, countsCases_badSOB, countsCases,
countsControls = {0:0, 1:0, 2:0}, {0:0, 1:0, 2:0}, {0:0, 1:0, 2:0}, {0:0,
1:0, 2:0}
total_badSOB_cases, total_goodSOB_cases = 0, 0
for i, (dz_case, mo_case, sob_case, pheno_case) in
enumerate(cases):
dz_control, mo_control, sob_control, pheno_control =
controls[i]
if sob_case == 1:
countsCases_badSOB[dz_case] =
countsCases_badSOB[dz_case] + 1
total_badSOB_cases += 1
elif sob_case == 0:
countsCases_goodSOB[dz_case] =
countsCases_goodSOB[dz_case] + 1
total_goodSOB_cases += 1
countsControls[dz_control] =
countsControls[dz_control] + 1
countsCases[dz_case] = countsCases[dz_case] + 1
#get expected numbers of cases, based on frequencies of
controls with 0, 1, or 2 disease alleles
expectedCases_goodSOB, expectedCases_badSOB, expectedCases =
[], [], []
for numDzAlleles in [0, 1, 2]:
freq_controls = countsControls[numDzAlleles] /
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float(n)
expectedCases_goodSOB.append(freq_controls *
float(total_goodSOB_cases))
expectedCases_badSOB.append(freq_controls *
float(total_badSOB_cases))
expectedCases.append(countsControls[numDzAlleles])
#calculate chisquared statistics...
#this is for association among just those born in bad months
chisqbad, pvalbad = stats.lchisquare([countsCases_badSOB[0],
countsCases_badSOB[1], countsCases_badSOB[2]], expectedCases_badSOB)
#this is for association among just those born in good
months
chisqgood, pvalgood =
stats.lchisquare([countsCases_goodSOB[0], countsCases_goodSOB[1],
countsCases_goodSOB[2]], expectedCases_goodSOB)
#this is for association, using all persons, but splitting
into obs/expected counts into good and bad cells
chisqsep, pvalsep =
stats.lchisquare([countsCases_goodSOB[0], countsCases_goodSOB[1],
countsCases_goodSOB[2], countsCases_badSOB[0], countsCases_badSOB[1],
countsCases_badSOB[2]], expectedCases_goodSOB + expectedCases_badSOB)
#this is for association, using all persons
chisqall, pvalall = stats.lchisquare([countsCases[0],
countsCases[1], countsCases[2]], expectedCases)
if pvalbad < 0.05:
ctsigbad += 1
if pvalgood < 0.05:
ctsiggood += 1
if pvalsep < 0.05:
ctsigsep += 1
if pvalall < 0.05:
ctsig += 1
cttotal += 1
print >>outfile, [countsCases_badSOB[0],
countsCases_badSOB[1], countsCases_badSOB[2]], [countsCases_goodSOB[0],
countsCases_goodSOB[1], countsCases_goodSOB[2]], [countsControls[0],
countsControls[1], countsControls[2]], pvalbad, pvalgood, pvalsep, pvalall
#print final tally of significant / nonsignificant tests...
print >>outfile, ctsiggood, ctsigbad, ctsigsep, ctsig,
cttotal
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